Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system

作者: Gabriel Torrens , Marcelo Pérez-Gallego , Bartolomé Moya , Marta Munar-Bestard , Laura Zamorano

DOI: 10.1371/JOURNAL.PONE.0181932

关键词: MicrobiologyInnate immune systemImmunityImmune systemLysozymeVirulencePeptidoglycanChemistryPattern recognition receptorPseudomonas aeruginosa

摘要: Antimicrobial resistance is a continuously increasing threat that severely compromises our antibiotic arsenal and causes thousands of deaths due to hospital-acquired infections by pathogens such as Pseudomonas aeruginosa, situation further aggravated the limited development new antibiotics. Thus, alternative strategies those targeting bacterial mechanisms, virulence or potentiating activity immune system resources are urgently needed. We have recently shown mutations simultaneously causing peptidoglycan recycling blockage β-lactamase AmpC overexpression impair P.aeruginosa. These findings suggested metabolism might be good target not only for fighting resistance, but also attenuation and/or potentiation innate weapons. Here we analyzed elements recognition proteins (PGRPs) lysozyme against P. aeruginosa. show while PGRPs very modest basal effect over their bactericidal dramatically increased in presence subinhibitory concentrations permeabilizing agent colistin. aeruginosa inhibitors seem play residual protective role even conditions. In contrast, demonstrate that, once permeability barrier overpassed, enhanced when inhibiting key components (such 3 AmpDs, AmpG NagZ), indicating decisive cell-wall direct peptidoglycan-binding supports, at least partially, these enzymes. Finally, blockade occurring with determines decrease PGRP2 lysozyme, linked quantitative changes cell-wall. results help delineate infections, β-lactam virulence, ultimately enhancing

参考文章(70)
Stuart B. Levy, Robert W. Jackson, Mark W. Silby, Craig Winstanley, Scott A.C. Godfrey, Pseudomonas genomes: diverse and adaptable Fems Microbiology Reviews. ,vol. 35, pp. 652- 680 ,(2011) , 10.1111/J.1574-6976.2011.00269.X
Pierre Joll�s, Jacqueline Joll�s, What's new in lysozyme research? Always a model system, today as yesterday. Molecular and Cellular Biochemistry. ,vol. 63, pp. 165- 189 ,(1984) , 10.1007/BF00285225
Robert D. Turner, Waldemar Vollmer, Simon J. Foster, Different walls for rods and balls: the diversity of peptidoglycan Molecular Microbiology. ,vol. 91, pp. 862- 874 ,(2014) , 10.1111/MMI.12513
Deepak Balasubramanian, Lisa Schneper, Hansi Kumari, Kalai Mathee, A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence Nucleic Acids Research. ,vol. 41, pp. 1- 20 ,(2013) , 10.1093/NAR/GKS1039
Jennifer L. Bishop, Erin C. Boyle, B. Brett Finlay, Deception point: peptidoglycan modification as a means of immune evasion. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 691- 692 ,(2007) , 10.1073/PNAS.0611133104
Julien Royet, Dipika Gupta, Roman Dziarski, Peptidoglycan recognition proteins: modulators of the microbiome and inflammation Nature Reviews Immunology. ,vol. 11, pp. 837- 851 ,(2011) , 10.1038/NRI3089
Alaa Ropy, Gabriel Cabot, Irina Sánchez-Diener, Cristian Aguilera, Bartolome Moya, Juan A. Ayala, Antonio Oliver, Role of Pseudomonas aeruginosa Low-Molecular-Mass Penicillin-Binding Proteins in AmpC Expression, β-Lactam Resistance, and Peptidoglycan Structure Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 3925- 3934 ,(2015) , 10.1128/AAC.05150-14
Keith A. Stubbs, John-Paul Bacik, G. Evan Perley-Robertson, Garrett E. Whitworth, Tracey M. Gloster, David J. Vocadlo, Brian L. Mark, The Development of Selective Inhibitors of NagZ: Increased Susceptibility of Gram-Negative Bacteria to β-Lactams ChemBioChem. ,vol. 14, pp. 1973- 1981 ,(2013) , 10.1002/CBIC.201300395
Tobias Dörr, Hubert Lam, Laura Alvarez, Felipe Cava, Brigid M. Davis, Matthew K. Waldor, A Novel Peptidoglycan Binding Protein Crucial for PBP1A-Mediated Cell Wall Biogenesis in Vibrio cholerae PLoS Genetics. ,vol. 10, pp. e1004433- ,(2014) , 10.1371/JOURNAL.PGEN.1004433
Karl E Griswold, Jenna L Bement, Charlotte C Teneback, Thomas C Scanlon, Matthew J Wargo, Laurie W Leclair, Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections. Bioengineered bugs. ,vol. 5, pp. 143- 147 ,(2014) , 10.4161/BIOE.28335